Literature DB >> 24050818

Pathological features of FTLD-FUS in a Japanese population: analyses of nine cases.

Zen Kobayashi1, Ito Kawakami, Tetsuaki Arai, Osamu Yokota, Kuniaki Tsuchiya, Hiromi Kondo, Yoko Shimomura, Chie Haga, Naoya Aoki, Masato Hasegawa, Masato Hosokawa, Kenichi Oshima, Kazuhiro Niizato, Hideki Ishizu, Seishi Terada, Mitsumoto Onaya, Manabu Ikeda, Kiyomitsu Oyanagi, Imaharu Nakano, Shigeo Murayama, Haruhiko Akiyama, Hidehiro Mizusawa.   

Abstract

We investigated the pathological features of frontotemporal lobar degeneration (FTLD) with fused in sarcoma protein (FUS) accumulation (FTLD-FUS) in the Japanese population. Only one out of nine FTLD-FUS cases showed pathology that corresponds to atypical FTLD with ubiquitin-positive inclusions (aFTLD-U). Five were basophilic inclusion body disease (BIBD) and two were neuronal intermediate filament inclusion disease. The last case was unclassifiable and was associated with dystrophic neurites (DNs) as the predominant FUS pathology. The results of this study indicate an ethnic difference from western countries. In Japan, BIBD is the most common subtype of FTLD-FUS and aFTLD-U is rare, a finding which contrasts with aFTLD-U being the most common form in western countries. Immunohistochemical analyses of these FTLD-FUS cases reveal that FUS abnormally accumulated in neuronal cytoplasmic inclusions (NCIs) and DNs has an immunohistochemical profile distinct from that of normal, nuclear FUS. NCIs and DNs are more readily stained than the nuclei by antibodies to the middle portion of FUS. Antibodies to the carboxyl terminal portion, on the other hand, stain the nuclei more readily than NCIs and DNs. Such an immunohistochemical profile of NCIs and DNs was similar to that of cytoplasmic granular FUS staining which we previously reported to be associated with dendrites and synapses. Redistribution of FUS from the nucleus to the cytoplasm could be associated with the formation of abnormal FUS aggregates in FTLD-FUS.
© 2013.

Entities:  

Keywords:  BIBD; Frontotemporal lobar degeneration; Fused in sarcoma; Immunohistochemistry; NIFID; aFTLD-U

Mesh:

Substances:

Year:  2013        PMID: 24050818     DOI: 10.1016/j.jns.2013.08.035

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  2 in total

Review 1.  The role of FUS gene variants in neurodegenerative diseases.

Authors:  Hao Deng; Kai Gao; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

2.  Chorea as a clinical feature of the basophilic inclusion body disease subtype of fused-in-sarcoma-associated frontotemporal lobar degeneration.

Authors:  Ito Kawakami; Zen Kobayashi; Tetsuaki Arai; Osamu Yokota; Takashi Nonaka; Naoya Aoki; Kazuhiro Niizato; Kenichi Oshima; Shinji Higashi; Omi Katsuse; Masato Hosokawa; Masato Hasegawa; Haruhiko Akiyama
Journal:  Acta Neuropathol Commun       Date:  2016-04-04       Impact factor: 7.801

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.